Genome-wide profiling of promoter methylation in human

Area of Science:

• Genomics
• Epigenetics
• Cancer Biology

Background:

• DNA methylation in gene promoter regions is crucial for gene silencing and tumor-suppressor gene inactivation in cancer.
• Genome-wide profiling of promoter methylation remains underexplored.
• Aberrant methylation patterns are implicated in carcinogenesis.

Purpose of the Study:

• To develop and validate a novel genome-wide method for analyzing DNA methylation in promoter regions.
• To investigate the frequency and patterns of aberrant promoter methylation in human cancer.
• To identify potential epigenetic alterations contributing to cancer development.

Main Methods:

• Developed Microarray-based Integrated Analysis of Methylation by Isoschizomers (MIAMI) for genome-wide promoter methylation profiling.
• Utilized a microarray targeting promoter regions of 8091 human genes.
• Compared resistance to methylation-sensitive (HpaII) and insensitive (MspI) restriction enzymes to assess methylation status.

Main Results:

• Demonstrated the utility of MIAMI in identifying epigenetic mutations in cancer.
• Found a higher frequency of aberrant promoter hypermethylation in cancer than previously hypothesized.
• Identified CpG-poor promoter sequences as sensitive to demethylation activity in cancer, potentially activating oncogenes.

Conclusions:

• The MIAMI method provides a reliable approach for genome-wide promoter methylation analysis.
• Aberrant promoter hypermethylation is a frequent event in cancer, impacting tumor-suppressor genes.
• CpG-poor genes are susceptible to hypomethylation-induced oncogene activation in the context of cancer epigenetics.